Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New test could keep babies from contracting deadly infections

31.07.2006
FDA OKs use of screening test during labor

The Food and Drug Administration on Tuesday approved a new test studied at the University of Florida that could lead to better screening for the most common cause of infection in newborn babies.

Passed from mother to child during birth, group B streptococcus can cause sepsis, pneumonia, meningitis, neurological damage and, in a small percentage of newborns, even death.

Although all women are tested for group B streptococcus during pregnancy, current screening methods can leave some babies at risk for contracting an infection from the bacterium. But the new test, which UF researchers studied for several months as part of a clinical trial, allows health-care workers to quickly screen mothers during labor, improving the odds that babies will receive preventive care so they will not be infected during delivery.

"Without any intervention, (group B strep) is the most common cause of early-onset infection in newborns," said Rodney Edwards, M.D., a UF assistant professor of obstetrics and gynecology in the College of Medicine who led the clinical trial at UF, one of six sites to study the test. "It can cause sepsis, meningitis and pneumonia. The likelihood of dying if you are a newborn is 5 percent. (With meningitis) even if the baby makes it through the infection there is a chance of cerebral palsy and cognitive delay."

The new group B strep test, developed by the California-based company Cepheid, allows doctors to screen for the bacterium during labor. Currently, women are screened for the organism a few weeks before birth because it takes a few days to receive results from the lab. But because some women do not contract the organism until after they are tested, some babies are still at risk for infection.

The first clinical molecular diagnostic test the FDA has approved, the technology can be adapted to detect other infections such as avian flu and even the deadly bug methicillin-resistant Staphylococcus aureus, Cepheid officials say.

About one-quarter of women carry group B streptococcus in their bodies, according to the Centers for Disease Control and Prevention. The bacterium, typically found in the rectum and vaginal tract, causes few problems for adults, but in babies, whose immune systems can't fend off bacterial invaders as easily, it can be deadly. The germ differs from group A streptococcus, which causes strep throat.

Only one to two of every 1,000 babies born develop group B streptococcus infections within their first week of life, and most of the children who contract the bug do not develop problems. But of the babies who develop sepsis, meningitis, pneumonia or other complications from group B streptococcus, about 15 percent die, according to the American College of Obstetricians and Gynecologists.

Federal guidelines require doctors to screen all women for the organism between 35 and 37 weeks of pregnancy. Women who test positive are then treated with antibiotics during labor.

"The patients we worry about are the ones who go into labor before their culture is done," said Amy Murtha, an assistant professor of obstetrics and gynecology at Duke University, who was not involved with the clinical trial. "It would be helpful in those instances to have a rapid test to screen for group B strep."

Edwards said the Cepheid test takes about 75 minutes to yield an answer and can be performed by health-care workers in the hospital, instead of in a lab.

The test uses technology known as a polymerase chain reaction, meaning it can amplify a small sample of DNA from a vaginal swab to detect the virus. Unlike other tests using this technology, Cepheid's test does not require the sample to be separately prepared prior to running the test. A nurse can insert the patient's sample directly into the self-contained test. This is what makes it so easy, Edwards said.

UF nurses performed the test on women in labor during the clinical trial. Lab technicians also tried out the test to screen pregnant women prior to labor. At UF, about 240 women were screened with the Cepheid test, Edwards said.

"The test seems to perform quite well," Edwards said.

April Frawley Birdwell | EurekAlert!
Further information:
http://www.vpha.health.ufl.edu

More articles from Health and Medicine:

nachricht Nanoparticles as a Solution against Antibiotic Resistance?
15.12.2017 | Friedrich-Schiller-Universität Jena

nachricht Plasmonic biosensors enable development of new easy-to-use health tests
14.12.2017 | Aalto University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: First-of-its-kind chemical oscillator offers new level of molecular control

DNA molecules that follow specific instructions could offer more precise molecular control of synthetic chemical systems, a discovery that opens the door for engineers to create molecular machines with new and complex behaviors.

Researchers have created chemical amplifiers and a chemical oscillator using a systematic method that has the potential to embed sophisticated circuit...

Im Focus: Long-lived storage of a photonic qubit for worldwide teleportation

MPQ scientists achieve long storage times for photonic quantum bits which break the lower bound for direct teleportation in a global quantum network.

Concerning the development of quantum memories for the realization of global quantum networks, scientists of the Quantum Dynamics Division led by Professor...

Im Focus: Electromagnetic water cloak eliminates drag and wake

Detailed calculations show water cloaks are feasible with today's technology

Researchers have developed a water cloaking concept based on electromagnetic forces that could eliminate an object's wake, greatly reducing its drag while...

Im Focus: Scientists channel graphene to understand filtration and ion transport into cells

Tiny pores at a cell's entryway act as miniature bouncers, letting in some electrically charged atoms--ions--but blocking others. Operating as exquisitely sensitive filters, these "ion channels" play a critical role in biological functions such as muscle contraction and the firing of brain cells.

To rapidly transport the right ions through the cell membrane, the tiny channels rely on a complex interplay between the ions and surrounding molecules,...

Im Focus: Towards data storage at the single molecule level

The miniaturization of the current technology of storage media is hindered by fundamental limits of quantum mechanics. A new approach consists in using so-called spin-crossover molecules as the smallest possible storage unit. Similar to normal hard drives, these special molecules can save information via their magnetic state. A research team from Kiel University has now managed to successfully place a new class of spin-crossover molecules onto a surface and to improve the molecule’s storage capacity. The storage density of conventional hard drives could therefore theoretically be increased by more than one hundred fold. The study has been published in the scientific journal Nano Letters.

Over the past few years, the building blocks of storage media have gotten ever smaller. But further miniaturization of the current technology is hindered by...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

AKL’18: The opportunities and challenges of digitalization in the laser industry

07.12.2017 | Event News

 
Latest News

Engineers program tiny robots to move, think like insects

15.12.2017 | Power and Electrical Engineering

One in 5 materials chemistry papers may be wrong, study suggests

15.12.2017 | Materials Sciences

New antbird species discovered in Peru by LSU ornithologists

15.12.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>